Nalaganje...

Cases of ALK-rearranged lung cancer with 5-year progression-free survival with crizotinib as initial precision therapy

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thorac Oncol
Main Authors: Rangachari, Deepa, Le, Xiuning, Shea, Meghan, Huberman, Mark S., VanderLaan, Paul A., Kobayashi, Susumu S., Costa, Daniel B.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659921/
https://ncbi.nlm.nih.gov/pubmed/28611010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.06.002
Oznake: Označite
Brez oznak, prvi označite!